Concordia Healthcare Corp. T.CXR.R

5 rate a buy, zero analysts rate CXR a "sell",

[MirrorWorldMan]

"Analysts await Concordia International Corp (NASDAQ:CXRX) to report earnings on November, 10. They expect $1.35 earnings per share, up 3.05% or $0.04 from last year’s $1.31 per share. CXRX’s profit will be $72.84M for 0.64 P/E if the $1.35 EPS becomes a reality. After $1.21 actual earnings per share reported by Concordia International Corp for the previous quarter, Wall Street now forecasts 11.57% EPS growth",
"Out of 9 analysts covering Concordia Healthcare Corp. (NASDAQ:CXRX), 5 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 56% are positive. Concordia Healthcare Corp. has been the topic of 18 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Laurentian on Tuesday, March 29. Scotia Capital maintained the stock with “Sector Outperform” rating in Tuesday, September 29 report. The firm has “Buy” rating given on Tuesday, August 11 by Canaccord Genuity. IBC initiated Concordia International Corp (NASDAQ:CXRX) on Monday, November 30 with “Sector Perform” rating. The firm earned “Sector Outperform” rating on Friday, October 16 by Scotia Capital. The firm earned “Buy” rating on Friday, October 16 by S&P Research. GMP Securities downgraded the stock to “Hold” rating in Monday, August 15 report. The firm earned “Hold” rating on Thursday, August 4 by TD Securities. The firm has “Neutral” rating given on Monday, August 15 by Goldman Sachs. Goldman Sachs initiated it with “Neutral” rating and $32 target price in Monday, June 6 report"
...I always did respect scooter over there at Scotia, I have beem on conference calls with him and his questions show insight